help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blondeau, J. P.
Right arrow Articles by Robel, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blondeau, J. P.
Right arrow Articles by Robel, P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*TESTOSTERONE

Endocrinology, Vol 110, 1926-1932, Copyright © 1982 by Endocrine Society

ARTICLES

Androgen-dependent regulation of androgen nuclear receptor in the rat ventral prostate

JP Blondeau, EE Baulieu and P Robel

Methods have been developed for the measurement of nonradioactive or radioactive dihydrotestosterone (DHT) bound to androgen receptor in rat ventral prostate nuclei (DHTRn). Using 1-day-castrated adult Sprague- Dawley rats (300--320 g body weight), the effects of testosterone (T) on nuclear androgen receptor formation were investigated in the absence and presence of cycloheximide or emetine. DHTRn was measured 4 h after injection of increasing amounts of T, and a maximal value of 14.6--17.8 pmol DHTRn/prostate was reached with doses of T greater than 37.5 micrograms. The amount of DHTRn 30 min after administration of 75 micrograms T was already 3 times greater than the concentration of cytosol receptor initially present in untreated castrated rats (2.0 +/- 0.3 pmol/prostate). In rats that received 2 mg cycloheximide ip 30 min before T, DHTRn did not exceed 5 pmol/prostate; in rats pretreated with 10 mg emetine administered at 1 h and 15 min before T, DHTRn did not exceed 8 pmol/prostate. These results suggest a two-component mechanism: 1) the translocation of preexisting cytosolic-receptor- hormone complexes to the nucleus; and 2) de novo formation of androgen receptor dependent on protein synthesis, which upon interaction with exogenous steroid is likewise accumulated in the nucleus. Progesterone (1 mg) and estradiol (0.6 mg) were also injected in amounts calculated to produce the same degree of occupancy of androgen receptor sites as did T. With both of these steroids, nuclear accumulation of androgen receptor was observed, but neither progesterone nor estradiol induced de novo synthesis of androgen receptor.


This article has been cited by other articles:


Home page
 Endocr. Rev.Home page
J. M. Kaufman and A. Vermeulen
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Endocr. Rev., October 1, 2005; 26(6): 833 - 876.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
D. P. Udrisar, M. I. Wanderley, R. C. C. Porto, C. L. P. Cardoso, M. C. L. Barbosa, M. C. Camberos, and J. C. Cresto
Androgen- and Estrogen-Dependent Regulation of Insulin-Degrading Enzyme in Subcellular Fractions of Rat Prostate and Uterus
Experimental Biology and Medicine, July 1, 2005; 230(7): 479 - 486.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
G. Pelletier
Effects of Estradiol on Prostate Epithelial Cells in the Castrated Rat
J. Histochem. Cytochem., November 1, 2002; 50(11): 1517 - 1524.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1982 by The Endocrine Society